Cancer Clinical Trial
Official title:
Combination of Cardiac Coherence to Physical Activity
APACCHE (Adapted Physical Activity and Cardiac Coherence in HEmatologic patients) study investigates effects of heart rate variability biofeedback training, combined with classical adapted physical activity, on health-related quality of life in patients previously treated for hematologic malignancies. It is a prospective, randomized clinical trial from University Hospital of Reunion Island. The main objective is evaluated with QLQ-C30 survey score differences.
Hematologic malignancies are aggressive cancers with significant long-term effects on
physical and psychological health, due to the disease itself or aggressive treatments.
Physical activity, with specific treatments, improves physical and psychological health in
solid tumors patients. However, in hematologic malignancies, there is unsatisfactory quality
of evidence that physical activity alone improves the various dimensions of quality of life.
Recent studies on heart-brain connections suggest that a high level of coherence in the heart
rate variability may induce psychophysiological positive effects. Cardiac coherence is
reached when the heart rhythm pattern becomes sine-wave-like at a frequency around 0.1 Hz.
This status can be increased by the mean of deep and slow breathing control and/or positive
emotions. By using a heart rate variability biofeedback training, previous studies have shown
effects on physiological variables such as reduction of blood pressure or increase of vagal
heart rate control, and also on psychological variables such as reduction of stress, anxiety,
and depression.
The APACCHE protocol investigate if cardiac coherence biofeedback training, associated with
an adapted physical activity program, can improve health related quality of life in adult
hematologic patients.
70 patients are randomly assigned to receive either ten sessions of cardiac coherence
biofeedback (CC-BF) and the adapted physical activity program (APA) or just APA. Both
interventions are conducted simultaneously over 12 weeks, with 10 sessions of CC-BF (45mn)
weekly and 24 sessions of APA (1h30) bi-weekly.
Data are collected at enrollment(T1), at 6 weeks (T2), at intervention ending at 12 weeks
(T3) and after a 24 weeks follow-up (T4).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|